Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer

NCT06538623 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasms
Neoplasm Metastasis
Hepatic Metastasis of Pancreatic Cancer

Interventions

DRUG: Liposome Irinotecan Injection II combined with Oxaliplatin, Fluorouracil, Leucovorin
DRUG: Tegodor

Sponsor

Ruijin Hospital